Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain excitatory neurons; strongest in smooth muscle cells | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 12 | 0.91 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 5325
Sealed predictions
- NXPH3 in dopamine neurons, braak-0.64 (p 0.065) → -0.14 (p 0.722)receipt 5332
Swarm cases
receipt 5332: NXPH3 in dopamine neurons, braak
- power
- full sample -0.43 (p 0.072, n 18), 95% CI -0.75 to +0.04. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.43 (p 0.075, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.57 (p 0.013, n 18). not the mix.
- skeptic
- leave-one-out range -0.56 to -0.36, sign flips 0; without severely affected donors -0.43 (p 0.072, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NXPH3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts